- Home
- IMCR vs SGML Comparison
IMCR vs SGML Comparison
Compare IMCR & SGML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCR
- SGML
- Stock Information
- Founded
- IMCR 2008
- SGML 2011
- Country
- IMCR United Kingdom
- SGML Brazil
- Employees
- IMCR N/A
- SGML N/A
- Industry
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- SGML Industrial Machinery/Components
- Sector
- IMCR Health Care
- SGML Industrials
- Exchange
- IMCR Nasdaq
- SGML Nasdaq
- Market Cap
- IMCR 1.8B
- SGML 743.4M
- IPO Year
- IMCR 2021
- SGML N/A
- Fundamental
- Price
- IMCR $33.81
- SGML $5.90
- Analyst Decision
- IMCR Buy
- SGML Strong Buy
- Analyst Count
- IMCR 8
- SGML 1
- Target Price
- IMCR $57.00
- SGML $16.00
- AVG Volume (30 Days)
- IMCR 270.5K
- SGML 2.3M
- Earning Date
- IMCR 11-05-2025
- SGML 11-14-2025
- Dividend Yield
- IMCR N/A
- SGML N/A
- EPS Growth
- IMCR N/A
- SGML N/A
- EPS
- IMCR N/A
- SGML N/A
- Revenue
- IMCR $356,145,000.00
- SGML $134,494,014.00
- Revenue This Year
- IMCR $31.83
- SGML $26.70
- Revenue Next Year
- IMCR $8.50
- SGML $42.31
- P/E Ratio
- IMCR N/A
- SGML N/A
- Revenue Growth
- IMCR 26.78
- SGML N/A
- 52 Week Low
- IMCR $23.15
- SGML $4.25
- 52 Week High
- IMCR $39.33
- SGML $15.56
- Technical
- Relative Strength Index (RSI)
- IMCR 46.61
- SGML 51.31
- Support Level
- IMCR $35.33
- SGML N/A
- Resistance Level
- IMCR $36.76
- SGML $6.63
- Average True Range (ATR)
- IMCR 1.43
- SGML 0.32
- MACD
- IMCR 0.00
- SGML -0.28
- Stochastic Oscillator
- IMCR 30.79
- SGML 85.05
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.
About SGML Sigma Lithium Corporation
Sigma Lithium Corp together with its direct and indirect subsidiaries, is a commercial producer of lithium concentrate. It holds a 100% interest in four mineral properties: Grota do Cirilo, Sao Jose, Santa Clara, and Genipapo, located in the municipalities of Aracuai and Itinga, in the Vale do Jequitinhonha region in the State of Minas Gerais, Brazil.